@FiercePharma: Top-read story Tues: Today's need-to-know on the Pfizer-AstraZeneca drama? It's all right here. Article | Follow @FiercePharma
@TracyStaton: Big news that doesn't involve Pfizer or AstraZeneca? Refreshing. First: Forest's new chief, Brent Saunders, will head up Actavis post-buyout. | Follow @TracyStaton
@EricPFierce: Canada orders Biolyse to halt production of injectable drug paclitaxel at a plant in Ontario. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: Sanofi steps up meningitis marketing amid lagging Menactra sales. FierceVaccines story | Follow @CarlyHFierce
> A federal judge in North Carolina ruled that punitive damages could not be assessed against Swiss drugmaker Novartis ($NVS) in a case alleging jaw injuries caused by its bone drugs Zometa and Aredia because of a lack of evidence that executives acted improperly. Report (reg. req.)
> U.K. cost watchdog NICE declined to approve Johnson & Johnson's ($JNJ) prostate cancer drug Zytiga for patients who have yet to receive chemotherapy. Story
> While cancer patients in the U.S. may have access to drugs not approved in the U.K., they often are more likely to be bankrupted by paying for them, a former Royal College of General Practitioners said in defending stands taken by NICE. Story
> A generic and three branded drugs from Johnson & Johnson ($JNJ), Forest Laboratories ($FRX) and H. Lundbeck used to treat alcoholism were found to reduce addiction. Story
> India's Dr. Reddy's Laboratories has shuffled top management, saying that it wanted to separate the roles of the chairman, CEO and managing director. Story
> The World Health Organization convened a meeting of experts to assess the international risk posed by the highly infectious and often lethal Middle East Respiratory Syndrome (MERS). Story
@FierceMedDev: ICYMI yesterday: Medtronic poaches GE exec to lead its $1.5B diabetes biz. Report | Follow @FierceMedDev
@VarunSaxena2: Tonix's sublingual formulation for fibromylagia reaches pivotal trial stage. Story | Follow @VarunSaxena2
@MichaelGFierce: Boston College team makes zinc nano-cages for 'smart' cancer drug delivery. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: 3-D printed prosthesis brings more dexterity to 12-year-old orphan in Haiti. More from MedCityNews | Follow @EmilyWFierce
> St. Jude Medical achieves first U.S. implants of its TAVR system. Story
> Medrobotics captures $26M in Series E cash for robotic surgery device. More
> Guided Therapeutics preps for a third shot at FDA approval for its cervical scanner. Article
Biotech News
@FierceBiotech: AstraZeneca adds an immuno-oncology collaboration for its pipeline star. News | Follow @FierceBiotech
@JohnCFierce: Not naming names, but everybody I talk to in the industry believes Pfizer's $AZN takeover is numbers driven, lousy for research. Everyone. | Follow @JohnCFierce
@DamianFierce: In which we learn that $PFE's Read always carries a coin with "Straight Talk" on one side and "Own It" on the other. Bloomberg story | Follow @DamianFierce
@EmilyMFierce: Naturally occurring molecule could treat Type 2 diabetes. ICYMI from FierceBiotech Research | Follow @EmilyMFierce
> J&J scouts for 50 Bay biotechs with new Janssen incubator. News
> PhIII eye drug failure? Not at all, says an optimistic Gene Signal. Story
> FDA breaks silence on biosimilars with long-awaited proposal. Report
> Isis heralds positive PhII diabetes results from leading antisense drug. Article
Drug Delivery News
> Alnylam's hepatitis B therapy shows promise in animal studies. Article
> Boston College team makes zinc nano-cages for 'smart' cancer drug delivery. Story
> North Carolina State researchers 'smuggle' drugs into cancer cells with ATP. Report
> MIT researchers deliver low doses of siRNA to lung endothelial cells. Story
> Nanoparticles weaken and then kill cancer cells with two-drug timed release. More
Diagnostics News
> AC Immune and Piramal Imaging link in Alzheimer's imaging agent development deal. Report
> Cinven reportedly puts French Dx outfit Sebia up for sale. More
> Counsyl, armed with $28M, begins big rollout of BRCA and other predictive genetic tests. Story
> Abbott commits to companion Dx development for a promising Idera drug. Article
> Smartphone app shows promise monitoring voice patterns to predict biopolar episodes. More
Pharma Marketing News
> Surprise success of Insys' opioid painkiller Subsys raises eyebrows, More
> Big Biotech beats Big Pharma with best-selling 2013 drug launches. News
> Top GSK exec faces life in Chinese prison for alleged 'massive bribery network.' Story
> Fresh off a TV ad launch, Eisai plots another 200-rep add to Belviq sales force. Article
> Teva's years of Copaxone brand-building pay off in new formula's launch. More
> Sanofi looks to make a splash with meningitis booster-shot push. Story
And Finally... The Advertising Standards Authority (ASA) in the U.K. told Johnson & Johnson ($JNJ) it must discontinue using an advertisement that suggested drinking its Benecol yogurt drinks can lower cholesterol. Story